Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles

Chronic viral infections induce oxidative stress that can cause a number of concomitant diseases, e.g. cardio-vascular diseases or metabolic disorders. Therefore, a sufficient treatment of oxidative stress may be of benefit for the patient to prevent further diseases.

Shingles (herpes zoster infection) have been successfully treated with antioxidative substances like high-dose vitamin C for ages. Not only the acute symptoms can be diminished by high-dose vitamin C. Even long-term sequelae, like painful post-herpetic neuropathy, may be mitigated or even fully avoided.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Virus Diseases DNA Virus Infections Herpes Simplex Herpes Zoster Herpesviridae Infections Infections Skin Diseases Skin Diseases, Infectious Skin Diseases, Viral Skin and Connective Tissue Diseases Varicella Zoster Virus Infection

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Praxis Dr. Schencking, Rheinstr. 77a

Ransbach-Baumbach, Rhineland-Palatinate, 56235, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Due to the design of an Observational Cohort Study, no inclusion or exclusion criteria are named. The included patient group is described under "Cohort / Group".

Observational Criteria:

adult patients
acute viral infection (especially herpes zoster)
Primary Care patient
eligible for add-on therapy with vitamin C
willingness to provide pseudonymized data to the Sponsor

Treatment and study plan

Primary outcomes

Change of Pain Measured by VAS

Time frame: visit 1 - 3

VAS (minimum = 0 = no pain, maximum = 10 = extrem pain, change of pain measured by VAS

Sponsors and collaborators

Lead sponsor

Pascoe Pharmazeutische Praeparate GmbH

Industry

Collaborators

Dr. Loges & Co. GmbH

Registry information

Official study title

PASCORBIN 7.5g in the Treatment of Viral Infection, Especially Varicella Zoster Infection: An Observational Cohort Study

Acronym: 168

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Jun 17, 2009
Registry last updated: Dec 21, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed